Image

    Management of Polycystic Ovarian Syndrome: Looking Beyond the Ovaries

    April 2024 in “ Canadian Women s Health Today
    Maria Isidora Margarita Yap‐Garcia
    Studysummary This review suggests that "polycystic ovarian syndrome" is a misleading name, as the disorder involves complex metabolic and reproductive issues beyond ovarian dysfunction and may stem from factors affecting the fetus in utero.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on canadianwomenshealthtoday.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Recommendations From The 2023 International Evidence-Based Guideline For The Assessment And Management Of Polycystic Ovary Syndrome Human Reproduction · 2023
    2. Serum Anti-Müllerian Hormone as a Predictor of Polycystic Ovarian Syndrome Among Women of Reproductive Age BMC Women's Health · 2022
    3. Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee The Journal of Clinical Endocrinology and Metabolism · 2019